Breaking News
Get 50% Off 0
💎 Bargain Hunter: Undervalued stocks with massive upside potential
Get the list
Close

Akoya Biosciences Inc (AKYA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Akoya Biosciences's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Akoya Biosciences historical data, for real-time data please try another search
1.290 -0.070    -5.15%
07/07 - Closed. Currency in USD
Type:  Equity
Market:  United States
  • Volume: 715,252
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 1.290 - 1.640
Akoya Biosciences 1.290 -0.070 -5.15%

AKYA Recent Sentiments

 
This page features our user's sentiments regarding the Akoya Biosciences Inc share. They are displayed on both charts of different time periods and in a detailed table.
Start Date Username Call Open Rate End Date Chg. %
May 21, 2025 David Carrillo   1.300 May 26, 2025 @ 1.260 -3.08%
May 21, 2025 Mohamed Ali   1.310 Jun 13, 2025 @ 1.230 -6.11%
May 13, 2025 JAIME ARNOTT...   1.010 May 22, 2025 @ 1.330 +31.68%
Mar 19, 2025 Milan Jones   1.685 Apr 11, 2025 @ 1.235 -26.71%
Jan 13, 2025 선일 유   2.930 Jan 20, 2025 @ 2.820 +3.75%
Jan 10, 2025 Marco Talluto   3.360 Jan 13, 2025 @ 2.950 -12.20%
Dec 09, 2024 Fernando Serva   2.150 Dec 16, 2024 @ 2.330 +8.37%
Dec 06, 2024 mustafa egemen devrim   2.091 Dec 06, 2024 @ 2.110 -0.91%
Nov 22, 2024 بدر الرياض   2.130 Dec 13, 2024 @ 2.280 +7.04%
Nov 18, 2024 سلطان الهملان   2.220 Dec 13, 2024 @ 2.280 +2.70%
Nov 12, 2024 Fernando Serva   3.202 Nov 18, 2024 @ 2.215 -30.82%
Oct 07, 2024 Harun Beldek   3.171 Nov 01, 2024 @ 2.740 -13.59%
Aug 09, 2024 Osama Marouf   2.180 Aug 30, 2024 @ 2.550 +16.97%
Jun 25, 2024 süleyman erdoğan   2.380 Jul 01, 2024 @ 2.200 -7.56%
Jun 21, 2024 süleyman erdoğan   2.380 Jul 12, 2024 @ 2.320 -2.52%
May 30, 2024 süleyman erdoğan   2.300 Jun 03, 2024 @ 2.080 -9.57%
May 24, 2024 Talip Altun   1.960 Jun 14, 2024 @ 2.210 -12.76%
May 16, 2024 cutpic pic   2.780 Jun 07, 2024 @ 2.050 -26.26%
May 14, 2024 Emre Dincel   2.900 Jun 07, 2024 @ 2.050 -29.31%
Mar 18, 2024 Fahd Saud   4.910 Mar 18, 2024 @ 4.920 +0.20%
Jan 18, 2024 mao dea   5.000 Jan 22, 2024 @ 5.160 +3.20%
Jul 12, 2023 Yunus KARABABA   7.390 Jul 12, 2023 @ 7.390 0.00%
Jun 13, 2023 Daniele De Pace   6.440 Jun 14, 2023 @ 7.950 +23.45%
Jun 08, 2023 Riccardo Bacheca   4.480 Nov 30, 2023 @ 4.600 +2.68%
Apr 17, 2023 Joshua Archard   7.550 Apr 24, 2023 @ 7.170 -5.03%
Jun 22, 2022 Robbert Kuipers   10.590 Jun 27, 2022 @ 11.700 +10.48%
Sep 08, 2021 Valeriy Klimentyev   15.010 Oct 01, 2021 @ 14.040 +6.46%
Aug 12, 2021 Valeriy Klimentyev   17.590 Sep 03, 2021 @ 15.680 +10.86%
Jul 28, 2021 dulat niyazov   17.210 Aug 20, 2021 @ 15.840 -7.96%
Jun 15, 2021 Temirlan Temirlan   19.450 Jul 09, 2021 @ 19.330 -0.62%
May 07, 2021 Temirlan Temirlan   19.280 May 28, 2021 @ 20.820 +7.99%
Apr 28, 2021 Muhammad Qasim Nagori   22.000 May 21, 2021 @ 21.950 +0.23%
Apr 26, 2021 Ayana Gubasheva   22.270 May 21, 2021 @ 21.950 -1.44%
Apr 16, 2021 Андрей Ванькевич   0.000 Apr 16, 2021 @ 0.000 0.00%
Apr 16, 2021 Евгений Высоцкий   0.000 May 07, 2021 @ 19.750 -100.00%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AKYA Comments

Write your thoughts about Akoya Biosciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email